Orasi Medical company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

orasimedical.com

Executives

5

Board of Directors

1

Orasi Medical Board of Director

1 Board of directors

Orasi Medical has 1 board of directors, including Michael Jerstad.

Name

Firm

Work History

Other Seats

Michael Jerstad

Mike Jerstad is a Partner at PrairieGold Venture Partners where he oversees all aspects of the firm's investment activities, from sourcing, structuring and negotiating investments to serving as a board member for portfolio companies. He currently serves on the boards of Grand Prairie Foods, Chronix Biomedical, PetMedicus Labs, Orasi Medical, and LineaGen. Prior to joining PrairieGold, Mike worked in Piper Jaffray's Healthcare Investment Banking Group in its Minneapolis and San Francisco offices, specializing in merger and acquisition advisory services and public and private equity financing. Before Piper, Mike was an Attorney at Briggs and Morgan, P.A. in Minneapolis, specializing in business litigation, employment law and contracts. He received his B.A. from Tufts University, his J.D. from Georgetown University and his M.B.A. from the University of Chicago. jerstad@pgvp.

Orasi Medical

Name

Michael Jerstad

Firm

Work History

Mike Jerstad is a Partner at PrairieGold Venture Partners where he oversees all aspects of the firm's investment activities, from sourcing, structuring and negotiating investments to serving as a board member for portfolio companies. He currently serves on the boards of Grand Prairie Foods, Chronix Biomedical, PetMedicus Labs, Orasi Medical, and LineaGen. Prior to joining PrairieGold, Mike worked in Piper Jaffray's Healthcare Investment Banking Group in its Minneapolis and San Francisco offices, specializing in merger and acquisition advisory services and public and private equity financing. Before Piper, Mike was an Attorney at Briggs and Morgan, P.A. in Minneapolis, specializing in business litigation, employment law and contracts. He received his B.A. from Tufts University, his J.D. from Georgetown University and his M.B.A. from the University of Chicago. jerstad@pgvp.

Other Seats

Orasi Medical

Orasi Medical Management Team

5 Team Members

Orasi Medical has 5 executives. Orasi Medical's former Chief Executive Officer, President is Rajiv Khosla.

Name

Work History

Title

Status

Rajiv Khosla

Chief Executive Officer, President

Former

Shawn Lyndon

Chief Executive Officer, President

Former

Dallas Steiner

Chief Financial Officer

Former

Todd A Verdoorn

Chief Security Officer

Former

Steve Lebow

Chief Medical Officer

Former

Name

Rajiv Khosla

Shawn Lyndon

Dallas Steiner

Todd A Verdoorn

Steve Lebow

Work History

Title

Chief Executive Officer, President

Chief Executive Officer, President

Chief Financial Officer

Chief Security Officer

Chief Medical Officer

Status

Former

Former

Former

Former

Former

You May Also Like

Alzeca Biosciences Logo
Alzeca Biosciences

Alzeca Biosciences develops imaging compounds to diagnose Alzheimer's disease at the earliest stages. Early detection of Alzheimer's is critical as disease pathology begins to accumulate 10+ years prior to cognitive onset of the disease. As a result, early detection of Alzheimer's pathology offers the patient an opportunity to take counteractive measures at a point where the disease may still be treatable.

N
NeuroVision Imaging

NeuroVision Imaging is developing retinal imaging technology for early detection and monitoring of Alzheimer's disease.

N
Neurotrack Technologies

Neurotrack is a digital medicine solution for Alzheimer's disease, giving people direct access to the scientifically validated digital diagnostic and therapeutic to delay or prevent memory health conditions.

Darmiyan Logo
Darmiyan

Darmiyan develops fully automated proprietary software that inputs human brain MRIs and produces maps that detect Alzheimer's disease up to fifteen years before symptoms. Its mission is to create a fast, non-invasive, inexpensive, precise, and globally accessible tool for brain health screening and monitoring. Darmiyan's technology provides a platform for presymptomatic diagnosis of neurodegenerative disorders, with precise quantification and localization of microscopic abnormality in the brain.

A
ADispell

ADispell is a pharmaceutical development company with technology related to Alzheimers, cognition-loss disease, drug addiction, and other CNS areas. Three lead compounds have been identified for this platform technology and in vivo experiments have produce clear evidence of improved cognition and learning in impaired animals. Our team will continue pre-clinical work with the goal of licensing our development to a pharma partner. These deals have closed for $100s of millions of dollars.

Cytox Logo
Cytox

Cytox is developing a diagnostic test and therapeutic cures for Alzheimer's Disease. The company is a university spin-out based on academic research into the role of the cell cycle in neuro-degenerative diseases.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.